Acteos SA
PAR:EOS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Acteos SA
PAR:EOS
|
FR |
|
Lekoil Ltd
LSE:LEK
|
US |
|
Logansport Financial Corp.
OTC:LOGN
|
US |
|
Shufersal Ltd
OTC:SHUFF
|
IL |
|
Mainz Biomed NV
F:4TO
|
DE |
|
E
|
Elite Express Holding Inc
NASDAQ:ETS
|
US |
|
I
|
Interactive Health Network
OTC:IGRW
|
US |
|
S
|
Sungwoo Electronics Co Ltd
KOSDAQ:081580
|
KR |
|
Morphic Holding Inc
NASDAQ:MORF
|
US |
|
S
|
Samhwa Crown & Closure Co Ltd
KRX:004450
|
KR |
|
K
|
Kellogg Co
F:KEL
|
US |
|
M
|
MillerKnoll Inc
XBER:MHR
|
US |
|
MTR Corp Ltd
F:MRI
|
HK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EOS's stock price target?
Not Available
EOS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Acteos SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 11 years is 3%.